Page last updated: 2024-09-03

fullerene c60 and Leukemia

fullerene c60 has been researched along with Leukemia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Franskevych, DV; Grebinyk, DM; Grynyuk, II; Matyshevska, OP; Prylutska, SV	1
Drobot, LB; Franskevych, DV; Grynyuk, II; Matyshevska, OP; Pasichnyk, GV; Petukhov, DM; Prylutska, SV; Ritter, U	1
Durdagi, S; Grdadolnik, SG; Hodoscek, M; Koukoulitsa, C; Mavromoustakos, T; Papadopoulos, MG; Simcic, M	1
Burlaka, AP; Golub, AA; Matyshevska, OP; Potebnya, GP; Prylutska, SV; Prylutskyy, YI; Ritter, U; Scharff, P	1
Berezhnaya, LSh; Faingold, II; Gubaidullin, AT; Gubskaya, VP; Konovalova, NP; Kotelnikova, RA; Litvinov, IA; Morozov, VI; Nuretdinov, IA	1

Reviews

1 review(s) available for fullerene c60 and Leukemia

Article	Year
Strategies in the rational drug design. Current medicinal chemistry, 2011, Volume: 18, Issue:17 Topics: Antineoplastic Agents; Cannabinoids; Drug Design; Fullerenes; HIV Protease; HIV Protease Inhibitors; Leukemia; Ligands; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Peptide Synthases; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Receptors, Cannabinoid; Receptors, Drug	2011

Article

Year

Strategies in the rational drug design.

Current medicinal chemistry, 2011, Volume: 18, Issue:17

Topics: Antineoplastic Agents; Cannabinoids; Drug Design; Fullerenes; HIV Protease; HIV Protease Inhibitors; Leukemia; Ligands; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Peptide Synthases; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Receptors, Cannabinoid; Receptors, Drug

2011

Other Studies

4 other study(ies) available for fullerene c60 and Leukemia

Article	Year
Enhanced cytotoxicity of photoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells. Experimental oncology, 2015, Volume: 37, Issue:3 Topics: Animals; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fullerenes; Humans; Leukemia; Mice; Reactive Oxygen Species	2015
Photocytotoxic effect of C60 fullerene against L1210 leukemic cells is accompanied by enhanced nitric oxide production and p38 MAPK activation. Experimental oncology, 2016, Volume: 38, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Enzyme Activation; Fullerenes; Leukemia; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Photosensitizing Agents; Ultraviolet Rays	2016
Effect of the visible light irradiation of fullerene-containing composites on the ROS generation and the viability of tumor cells. Experimental oncology, 2006, Volume: 28, Issue:2 Topics: Animals; Carcinoma, Ehrlich Tumor; Fullerenes; Leukemia; Light; Photochemotherapy; Rats; Rats, Wistar; Reactive Oxygen Species; Thymus Gland	2006
Synthesis, structure and biological activity of nitroxide malonate methanofullerenes. Organic & biomolecular chemistry, 2007, Mar-21, Volume: 5, Issue:6 Topics: Animals; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Cyclophosphamide; Electron Spin Resonance Spectroscopy; Fullerenes; Leukemia; Male; Mice; Models, Molecular; Xenograft Model Antitumor Assays	2007